Dermatomyositis autoantigen CHD4 forms immune stimulatory complexes with endogenous DNA

Exp Dermatol. 2023 Jul;32(7):965-974. doi: 10.1111/exd.14799. Epub 2023 Mar 30.

Abstract

Dermatomyositis (DM) is an idiopathic inflammatory myopathy belonging to the spectrum of autoimmune connective tissue diseases. DM patients present with antinuclear antibodies against Mi-2, also known as Chromodomain-helicase-DNA-binding protein 4 (CHD4). CHD4 is upregulated in DM skin biopsies and could potentially affect DM pathophysiology as it binds endogenous DNA with a high affinity (KD = 0.2 nM ± 0.076 nM) and forms CHD4-DNA complexes. The complexes are localized in the cytoplasm of UV-radiated and transfected HaCaTs and amplify the expression of interferon (IFN) regulated genes and the amount of functional CXCL10 protein stronger than DNA alone. The enhancement of the type I IFN pathway activation in HaCaTs through CHD4-DNA signalling suggests a possible mechanism for the sustainment of the pro-inflammatory vicious cycle in DM skin lesions.

Keywords: Mi-2 nucleosome Remodelling and deacetylase complex; autoantigen; autoimmunity; dermatomyositis; interferon.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigen-Antibody Complex*
  • Autoantigens / genetics
  • DNA
  • DNA Helicases / genetics
  • Dermatomyositis*
  • Humans
  • Mi-2 Nucleosome Remodeling and Deacetylase Complex

Substances

  • Antigen-Antibody Complex
  • Autoantigens
  • DNA
  • DNA Helicases
  • CHD4 protein, human
  • Mi-2 Nucleosome Remodeling and Deacetylase Complex